Home
Latest
Gravitas
World
India
Entertainment
Sports
Opinions
videos
Photos
TV Shows
Science
Tech
Live TV
Latest
Gravitas
World
India
Entertainment
Sports
Opinions
videos
Photos
TV Shows
Science
Tech
Wion
/
World
/
Russia's temporary approval for Avifavir to treat COVID-19
Russia's temporary approval for Avifavir to treat COVID-19
Russia will start giving its first drug approved to treat COVID-19 to patients next week
Trending Topics
russia
russia covid-19
russia coronavirus
russia covid-19 drug
russia covid-19 cases
russia top news
Avifavir
avifavir drug
WION
wion news
Trending Videos
Indian army and J&K police recover weapons cache in Kupwara
New brain discovery could aid neurological disease studies
Indonesia ferry tragedy: Divers recover three bodies as 126 remain missing
Mumbai BMW crash: Speeding car kills three, one critically injured
South Africa: Police investigating possible links between multiple tragic murders
9 women found dead near Johannesburg: South Africans rally, demand 'enough' to femicide
Oxford United's new clothing line featured 'United 93' phase
Big Business Bet: Taj’s GCC playbook amid West Asia conflict
Trump defends AI amid growing alarm, announces new 'AI force' and promises an 'AI czar'
Nepal Flash Floods: At least 1,050 dead And 118 Nepalese rescued from disaster zone
Indonesia ferry tragedy: Divers deployed to shipwreck to search for missing people
Russia holds first parliamentary elections since the beginning of the Ukraine war
Focus: The future of environment and climate dynamics
NASA research plane reaches 61,000 feet over Panama
NYC hosts 'paws on parade' as furry fashionistas take center stage
US-Iran war: Tehran draws red lines — seven demands before any peace talks
Pyongyang dismisses US, western pressure over nuclear programme
US-Iran war: Tehran sets seven conditions to re-engage in talks with US
Gaza under attack: Health chief's son killed in IDF strikes
Russia's deadly Ukraine strikes kill 2 in Sumy, hit Dnipro mall
Report: Iran rebuilding Taleghan 2, nuclear site tied to past weapons research, hit twice by Israel
Elon Musk predicts AI could double US GDP growth to 4%
US President Trump bans American media outlets from White House
Big Bash League staging first match outside Australia in Chennai
AI safety debate: Trump says he will not tolerate attempts to slow AI growth
Pak: A series of counter terrorism operations in Khyber Pakhtunkhwa
Nepal forms 7-member panel to probe August 26 Bhotekoshi flood from source to downstream
From pumps to plugs: War reshapes energy choices
Indian Cinema bets big on mythology, brings ancient stories to modern audiences
Bolivia ends diesel subsidy amid IMF deal
Trump signs Russia sanctions bill into law, targets Moscow’s energy sector
Le Monde says French defence ministry would give a military response
Neuralink helped one patient communicate using a synthetic voice
Man breaks open wall hiding hundreds of books since 15 years
IAF remembers Alfred Cooke's legendary Kalaikunda dogfight
Israel's President Herzog pardons Elor Azaria, clearing record despite IDF opposition
Former Chilean President Michelle Bachelet quits race to lead the UN
Kampala-Ankara rift deepens: Uganda suspends military ties, seeks Fred Lumbuye's extradition
US-Iran war: Iran executes man accused of providing intel to Mossad
Michelle Bachelet quits race to lead the UN
Russia-Europe tensions: Polish PM warns Russian attacks could test NATO's unity
Saudi vs Houthis: Houthis claim missiles & drones used in attack on key Saudi sites
Delhi voter roll shake-up: 3.31 million electors flagged in SIR review
Gaza: Over 280,000 children now attend UNRWA schools in tents
The Hague bans planned march following escalating anti-immigration riot
Putin: European leaders using war rhetoric to save falling ratings
Munich Mayor taps first keg to kick off Oktoberfest
Claude led 26% of Anthropic's AI R&D work
Nigeria: Protesters take to the streets, police fire shots
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)